capsida.com
Get leads like Capsida — and thousands more
Build targeted lists by tech stack, traffic, and more
Capsida Bio: The Invisible Gene Therapy Giant
How a stealthy biotech is quietly engineering the next generation of targeted AAVs
In a crowded gene therapy landscape where most companies shout from the rooftops, Capsida Biotherapeutics operates with surgical precision. With just 144 employees generating $22.3M in revenue, they're not chasing hype—they're engineering the delivery vehicles that will make gene therapy work for everyone.
"They're not building gene therapies—they're building the delivery vehicles that make gene therapies possible."
The AAV Platform Advantage
Capsida isn't just another gene therapy company—they're a platform play. By engineering novel Adeno-Associated Viruses (AAVs), they're solving the fundamental bottleneck in gene therapy: delivery. Their proprietary technology creates targeted, non-invasive vectors that can reach specific tissues without the systemic toxicity that has plagued the field. This isn't incremental improvement; it's a foundational shift in how we think about genetic medicine.
The Stealth Behemoth
With 86% of traffic coming from undefined sources and only 30% from organic search, Capsida operates in near-total stealth mode. Their top keyword—'capsida biotherapeutics' at 520 monthly searches—suggests brand recognition among industry insiders rather than public hype. This is a company that invests in R&D, not marketing. The 46% direct traffic indicates a dedicated following among biotech professionals and investors who know exactly where to find them.
The leadership team tells the story of serious scientific depth. CEO Peter Anastasiou brings decades of biotech experience, while co-founder Viviana Gradinaru—a Caltech professor and viral vector expert—provides the academic credibility that translates to platform validation. This isn't a team chasing the latest biotech bubble; they're building the infrastructure for the next decade of genetic medicine.
- Platform-first approach: Engineering delivery vehicles rather than single therapies
- Targeted AAVs: Solving the tissue specificity problem that limits current gene therapies
- Non-invasive delivery: Moving beyond invasive surgical procedures for vector administration
- Industry-leading talent: PhD-heavy team with deep viral vector expertise
- Revenue-generating: Unlike most preclinical biotechs, they're already generating $22M+
The Infrastructure Play
Capsida isn't betting on a single therapy—they're building the delivery platform that will power an entire generation of genetic medicines. For investors, this is a lower-risk, higher-upside proposition than traditional single-asset biotechs.
What tech stack does Capsida use?
How much traffic does Capsida get?
Traffic & Engagement
Traffic Sources
Where is Capsida's audience located?
What keywords does Capsida rank for?
5 keywordsHow is Capsida's SEO?
Open Graph Image
https://capsida.com/wp-content/uploads/capsida-logo-vectorRGB.svg
Meta Tags
Capsida Biotherapeutics - Engineering novel AAVs and developing the next generation of gene therapies
Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening disorders.
H1 Tags
Schema Types
What is Capsida's revenue?
Who works at Capsida?
Loading leads...
What do customers think of Capsida?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Capsida
What is Capsida's Revenue?
What does Capsida do?
How fast is Capsida growing?
What technologies does Capsida use?
Who are Capsida's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Capsida?
Contact Information
Export capsida.com Data
Download the complete tech stack, analytics, leads, and company data for capsida.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About capsida.com
Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening disorders.
Company Overview
capsida.com Social Media
Contact capsida.com
Email Addresses
Phone Numbers
Technology Stack
capsida.com uses 18 technologies across their website including Font Awesome, Google Fonts, reCAPTCHA, PHP, and more.
Fonts
Font Awesome, Google Fonts
Security
reCAPTCHA
Programming Languages
PHP
CMS
WordPress
Cloud & Hosting
Cloudflare
Privacy & Consent
CookieYes
Traffic & Audience
capsida.com receives approximately 7.8K monthly visitors and ranks #2,523,980 globally. The website has a bounce rate of 31% with visitors viewing an average of 2.2 pages per visit. Users spend an average of 1:34 on the site.
The majority of capsida.com's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is capsida.com?
What technologies does capsida.com use?
How do I contact capsida.com?
What are capsida.com's social media accounts?
Is capsida.com hiring?
How popular is capsida.com?
Related Searches
This page provides publicly available information about capsida.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit capsida.com directly at https://capsida.com.